Innovest Global Inc. (IVST)

[LivinLarge8]

News Innovest Global August Recap Includes Major Acquisition Announcement

CLEVELAND, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and services, and biotechnology, had a busy August which began with major Biotech news and ended with the announcement of a $30 million revenue pending acquisition.

Last Friday, Innovest detailed a pending acquisition, which would enter it solidly into the Building Materials industry with $30 million in annual revenue, and a growth plan. This transaction represents a substantial, over five-times increase in Innovest’s revenue, and entry into its third industry sector. Details included a months-long process that resulted in a signed Letter of Intent, agreed final structure, and a closing expected in mid-September.

Earlier in August, the fall Biotech conference schedule was released. “With the recently announced patent approval, and obtaining exclusive worldwide rights to the technology, we believe that now is the time to collaborate with other scientists that have technologies which serve Innovest’s mission and could benefit from the relationship,” said Dr. Dwain Morris-Irvin, Biotech Division President and the StemVax founder. Dr. Morris Irvin and his team will be attending two conferences this fall: the Society for Neuroscience (SFN) 48th annual meeting, “Neuroscience 2018”, November 3-7 in San Diego, CA, and the BIO Investor Forum October 17-18 in San Francisco, CA.

Innovest’s base operations continued to grow, including focused marketing efforts resulting in coverage in such publications as the Los Angeles Business Journal. Not only were sales once again at record levels, but the Call Center business is now generating double the baseline revenue it was generating just a few months ago, when it was acquired, highlighting managements focus on successful integration of acquired entities and helping them succeed.

The Company’s stock price grew 33.1% in August, from $.20 starting the month to closing August 31 at $.2663. Innovest maintains an unchanged free-trading float of 11,796,710 common shares with no convertible debts, no warrants or options outstanding, and employs 45.



https://globenewswire.com/news-release/2018/09/05/1565601/0/en/Innovest-Global-August-Recap-Includes-Major-Acquisition-Announcement.html